Targeted Therapies in Advanced Renal Cell Cancer


  • Sinan Karaaslan

Received Date: 15.05.2015 Accepted Date: 29.06.2015 Bull Urooncol 2015;14(3):210-213

In the last ten years developments in treatment of metastatic renal cell cancer (mRCC) provided unprecedented improvement in prognosis of this disease. In this review, treatment agents used in the treatment of mRCC were discussed by mechanisms of action. This review will provide an updated review of currently approved treatment options and newly studied agents will be mentioned. Finally current treatment choices are summarized.

Keywords: Renal cell carcinoma, immunotherapy, tyrosine kinase inhibitör, VEGF, mTORq

Full Text (Turkish)